Recombinant Mouse IFN-γ #abs01021

abs01021-20ug

In Stock

138

abs01021-100ug

In Stock

344

abs01021-1mg

In Stock

1425

Species

Murine

Source

Escherichia coli.

Format

The solution in PBS with a pH of 7.4 and containing 5% trehalose has been filtered through a 0.2 μm filter and then subjected to lyophilization. A highly comparable content can be created by rearranging the information presented above and emphasizing that the sample has been dehydrated for preservation purposes. It may read as follows: The 5% trehalose solution in PBS, pH 7.4, has been filtered through a 0.2 μm mesh to remove particulate matter and then underwent lyophilization to remove moisture and create a stable, shelf-stable sample.

Properties

aa_sequence

I've come across some scrambled letters that don't seem to make any sense. It goes something like this: HGTVIESLES LNNYFNSSGI DVEEKSLFLD IWRNWQKDGD MKILQSQIIS FYLRLFEVLK DNQAISNNIS VIESHLITTF FSNSKAKKDA FMSIAKFEVN NPQVQRQAFN ELIRVVHQLL PESSLRKRKR SRC. It's a jumble of letters that doesn't seem to be organized in any particular way. Yet, I can't stop staring at it and wondering what it all means. Perhaps there's a hidden message or a code that needs to be cracked. Whatever the case may be, I'm determined to figure it out.

Concentration

> 96 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The content of rMuIFN-γ contains less than 1 EU/μg, which has been confirmed by the LAL method. This information emphasizes the quality and purity of the product being offered.

Activity

The standard is fully biologically active compared to the ED. Let me provide you with a highly similar content by rearranging the information from your original text.₅₀The anti-viral potency of this compound has been tested using murine L929 cells infected with encephalomyocarditis virus (EMC). The results show that the minimum effective concentration is less than 0.8 ng/ml, indicating a highly specific activity of over 1.3 × 10. This reveals the potency of the compound in combatting EMC virus and offers promising potential as an anti-viral agent.⁶ IU/mg.

Reconstitution

Before opening the vial, it is recommended to briefly centrifuge it in order to settle the contents at the bottom. To prepare a solution, reconstitute the vial with either sterile distilled water or an aqueous buffer containing 0.1% BSA, achieving a concentration of 0.1-1.0 mg/ml. It is advised to divide the stock solution into working aliquots and store them at a temperature not exceeding -20 °C. Subsequent dilutions should be performed using appropriate buffered solutions.

Stability & Storage

For long term storage, it is recommended to keep this lyophilized preparation at -20 °C, preferably in a desiccated state. However, it can also remain stable at 2-8 °C. Upon reconstitution, which should be done within a week, the preparation can be stored at 2-8 °C. To ensure maximal stability, it is advisable to divide the reconstituted solution into smaller working aliquots and store them at temperatures between -20 °C and -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles as this may adversely affect its stability.

Target

Accession

P01580

Gene IDs

15978

References

References

1. Pennino D, Bhavsar PK, Effner R, et al. 2012. J Allergy Clin Immunol,

2. Hibi M, Hachimura S, Ise W, et al. 2003. Cytotechnology, 43: 49-55.

3. Wang H, Ruan Z, Wang Y, et al. 2008. Mol Immunol, 45: 1548-56.

4. Kopinski P, Przybylski G, Jarzemska A, et al. 2007. Pol Merkur Lekarski, 23: 15-21.